Sentinel lymph node biopsy using single-agent mapping tracer (blue dye) after neoadjuvant chemotherapy in a Brazilian cohort of breast cancer patients. Real world evidence.
Heloisa Magda ResendeMartina LichtenfelsIgor Camargo SoaresAngélica Araújo Cortines Laxe RenóAna Paula CunhaPedro Gustavo FalcãoCarolina Soares Pimentel PieroniBiazi Ricieri de AssisPaola CardosoPedro Henrique Adário MarassiRafael Dos Santos ReisPublished in: Acta cirurgica brasileira (2021)
The use of blue dye as a single-agent mapping tracer demonstrated an acceptable detection rate of 85.3%. Although the FNR was possible to be determined, the small sample size might overestimate this rate. The removal of three or more lymph nodes with single-agent mapping tracer might be indicated for breast cancer patients who converted to ycN0 after NAC in the Brazilian health public services, in which radioisotope tracer is not suitable.
Keyphrases
- sentinel lymph node
- neoadjuvant chemotherapy
- lymph node
- positron emission tomography
- pet imaging
- healthcare
- high resolution
- mental health
- locally advanced
- high density
- early stage
- public health
- computed tomography
- transcription factor
- highly efficient
- emergency department
- primary care
- radiation therapy
- ultrasound guided
- young adults
- aqueous solution
- human health
- health promotion
- real time pcr